ArticleMolecular biotechnology2024

Recombinant CXCL17 Treatment Alleviates Hyperoxia-Induced Lung Apoptosis and Inflammation In Vivo and Vitro by Activating the AKT Pathway: A Possible Therapeutic Approach for Bronchopulmonary Dysplasia.

Ping Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.